36 min listen
002: The Biopharma Exit Strategy With Dr. Francois Nader
002: The Biopharma Exit Strategy With Dr. Francois Nader
ratings:
Length:
36 minutes
Released:
May 4, 2020
Format:
Podcast episode
Description
Every emerging biopharma company shares a common goal: creating value for its employees, its board, its investors, and ultimately, patients. Along the way, that value creation might get a boost from an IPO, a merger, an acquisition, or steady growth as a private entity. On this episode of The Business Of Biotech, we talk with Dr. Francois Nader—a man who's orchestrated several wildly successful biotech exits—about why it's imperative to begin with the end in mind, and how to navigate your options when the time is right.
Released:
May 4, 2020
Format:
Podcast episode
Titles in the series (100)
Summer Sessions 3: Jeff Wolf Builds Heat Bio On Its Therapeutic Platform by Business Of Biotech